These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 33773550)
1. Treatment Outcome and Prognosis Factors of FIGO 2018 Stage III Cervical Cancer Patients Treated with Definitive Concurrent Chemoradiation in Vietnam. Phung HT; Truong MC; Nguyen LT; Dang ATV; Vu TH; Nguyen HT Asian Pac J Cancer Prev; 2021 Mar; 22(3):853-859. PubMed ID: 33773550 [TBL] [Abstract][Full Text] [Related]
2. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy. Chen CC; Wang L; Lin JC; Jan JS J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974 [TBL] [Abstract][Full Text] [Related]
3. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma. Pathy S; Kumar L; Pandey RM; Upadhyay A; Roy S; Dadhwal V; Madan R; Chander S Asian Pac J Cancer Prev; 2015; 16(12):5075-9. PubMed ID: 26163644 [TBL] [Abstract][Full Text] [Related]
4. Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes. Liang JA; Chen SW; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY Int J Gynecol Cancer; 2014 Jun; 24(5):901-7. PubMed ID: 23975081 [TBL] [Abstract][Full Text] [Related]
5. Toxicity and clinical outcomes with definitive three-dimensional conformal radiotherapy (3DCRT) and concurrent cisplatin chemotherapy in locally advanced cervical carcinoma. Dracham CB; Mahajan R; Rai B; Elangovan A; Bhattacharya T; Ghoshal S Jpn J Clin Oncol; 2019 Feb; 49(2):146-152. PubMed ID: 30452664 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer. Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808 [TBL] [Abstract][Full Text] [Related]
7. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group. Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333 [TBL] [Abstract][Full Text] [Related]
8. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors. Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809 [TBL] [Abstract][Full Text] [Related]
9. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066). Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K; Int J Gynecol Cancer; 2012 Oct; 22(8):1420-6. PubMed ID: 22932262 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of treatment results and prognostic factors in early-stage cervical carcinoma patients treated with postoperative radiotherapy or radiochemotherapy. Demirci S; Ozsaran Z; Ozsaran A; Yavas F; Demircioglu B; Hanhan M; Dikmen Y; Aras AB Eur J Gynaecol Oncol; 2012; 33(1):62-7. PubMed ID: 22439408 [TBL] [Abstract][Full Text] [Related]
11. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer]. Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966 [No Abstract] [Full Text] [Related]
12. Extended-field intensity-modulated radiation therapy combined with concurrent chemotherapy for cervical cancer with para-aortic lymph nodes metastasis. Liu X; Wang W; Meng Q; Zhang F; Hu K Jpn J Clin Oncol; 2019 Mar; 49(3):263-269. PubMed ID: 30668725 [TBL] [Abstract][Full Text] [Related]
13. A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer. Wang JQ; Wang T; Shi F; Yang YY; Su J; Chai YL; Liu Z Asian Pac J Cancer Prev; 2015; 16(14):5957-61. PubMed ID: 26320479 [TBL] [Abstract][Full Text] [Related]
14. [Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy]. Binbin T; Lingying W; Manni H; Jusheng A; Ning L Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):348-54. PubMed ID: 25030731 [TBL] [Abstract][Full Text] [Related]
16. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy. Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321 [TBL] [Abstract][Full Text] [Related]
17. Definitive chemoradiotherapy for cervical cancer: A 11-year population-based study. Kalampokas E; Macdonald G; Young H; Bednarek A; Kennedy AM; Cairns M; Parkin DE Eur J Cancer Care (Engl); 2020 May; 29(3):e13223. PubMed ID: 31944444 [TBL] [Abstract][Full Text] [Related]
18. Extended-field intensity-modulated radiotherapy and concurrent cisplatin-based chemotherapy for postoperative cervical cancer with common iliac or para-aortic lymph node metastases: a retrospective review in a single institution. Zhang G; Fu C; Zhang Y; Wang J; Qiao N; Yang Q; Cheng Y Int J Gynecol Cancer; 2012 Sep; 22(7):1220-5. PubMed ID: 22854654 [TBL] [Abstract][Full Text] [Related]
19. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women. Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676 [TBL] [Abstract][Full Text] [Related]
20. Extended field chemoradiation for cervical cancer patients with histologically proven para-aortic lymph node metastases after laparaoscopic lymphadenectomy. Marnitz S; Schram J; Budach V; Sackerer I; Vercellino GF; Sehouli J; Köhler C Strahlenther Onkol; 2015 May; 191(5):421-8. PubMed ID: 25413986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]